FDA Orders Tubes of the Product "Age Intervention Eyelash" Seized
Product Could Cause Decreased Vision and Blindness
Because Jan Marini Skin Research claims that their product Age Intervention Eyelash promotes eyelash growth, the FDA considers the product a drug. All drugs must be proven by the FDA to be safe and effective before they are legally allowed to be sold. Age Intervention Eyelash has not been approved by the FDA and is therefore considered by the FDA to be an unapproved drug.
In addition to the FDA considering Age Intervention Eyelash a drug, it also considers it an adulterated cosmetic, because of the fact that it contains a drug named bimatoprost.
The FDA warns about serious potential complications from the use of Age Intervention Eyelash, because Age Intervention Eyelash contains the ingredient bimatoprost. Bimatoprost is an ingredient in a FDA approved prescription drug that treats elevated pressure inside the eye. Patients taking the FDA approved prescription drug containing bimatroprost are in danger if they also use Age Intervention Eyelash. The extra dose of bimatroprost from the Age Intervention Eyelash may decrease the effectiveness of the prescription drug. The decreased effectiveness may increase the risk of optic nerve damage, which could possibly lead to decreased vision or even blindness.
Another serious potential complication with the use of Age Intervention Eyelash is, in some people, Age Intervention Eyelash may also cause swelling of the retina and inflammation of the eye which may cause decreased vision. These complications are due to the ingredient bimatoprost in the product.
The makers of Age Intervention Eyelash, Jan Marini Skin Research, Inc. notified the FDA that as of last year they have not manufactured or shipped any Age Intervention Eyelash product containing bimatoprost. Never the less, previously purchased product may still remain on consumers, dermatologists, and estheticians shelves.
The FDA is recommending that anyone who has Age Intervention Eyelash, to not use the product and discard it. If a person has used the product and is having any complications that they think might be related to the product, the FDA recommends they see a doctor. It is important that people heed the FDA's warnings regarding Age Intervention Eyelash because of the potential of serious complications related to its' use.
Published by RK
- Restasis: FDA Approved Eye Drops for Chronic Dry Eyes Restasis is an FDA approved prescription eye drop used in the treatment of chronic dry eye conditions in which the tear ducts do not produce tears on a regular basis.
- JANUMET: FDA Approved Drug in the Treatment of Resistant Type 2 Diabetes Offering an overview of the FDA approved drug, JANUMET, used to treat resistant type 2 diabetes.
- Orencia: FDA Approved Prescription Drug Improved Rheumatoid Arthritis For patients who suffer from rheumatoid arthritis, the use of Orencia may provide significant improvement in mobility.
- Enablex: FDA Approved Drug in the Treatment of Urological Complications Offering an overview of Enablex, an FDA approved drug used to treat urinary incontinence, urinary frequency and urinary urgency.
- Equetro: FDA Approved Treatment of Bipolar Disorder With more than two million individuals suffering from bipolar disorder, Equetro is becoming a commonly used prescription drug to control symptoms.
- Are Your Cosmetics Dangerous for Your Health?
- FDA Seizes Unapproved, Potentially Harmful Cosmetic Eye Product
- Set Your Sight on Super Vision Foods
- FDA Warning Letter Issued Against Eyelash Growth Medication
- Use Latisse to Grow Longer, Fuller, Darker Lashes like Brooke Shields
- Jan Marini Skin Research
- Ziagen: FDA Approved Cocktail Drug in Treatment HIV and AIDS Patients
|
|
4 Comments
Post a CommentMy goodness! Some things are just not worth it!
I guess there are always eyelash transplants if someone is desperate enough.
Oh gracious, what some people will do for vanity. Good info.
Excellent reporting! I never heard of this product.